Stock Information

• Regeneron (REGN) Down 12.1% Since Last Earnings Report: Can It Rebound?
  Fri, May 29, 2026 3:30 PM
• Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak
  Thu, May 28, 2026 8:00 PM
• Regeneron And Parabilis Target Undruggable Proteins As Valuation Draws Interest
  Thu, May 28, 2026 3:04 PM
• These 2 Cheap Biotech Stocks Offer Potential for Low-Beta Growth
  Thu, May 28, 2026 3:04 PM
• Why Apogee Slipped On Its Dupixent-Rivaling Eczema Results
  Wed, May 27, 2026 8:05 PM
• Investment Firm Closes Out Entire $18.1 Million Position in Biotech Stock, According to Latest SEC Filing
  Tue, May 26, 2026 6:49 PM
• Canaccord Cuts PT on Regeneron Pharmaceuticals (REGN), Cites a Disappointing Event
  Tue, May 26, 2026 12:44 PM
• Are Wall Street Analysts Predicting Regeneron Pharmaceuticals Stock Will Climb or Sink?
  Tue, May 26, 2026 11:56 AM
• Dr. Scott Gottlieb on Ebola outbreak: This is an outbreak that's out of control in West Africa
  Tue, May 26, 2026 8:23 AM
• Regeneron (REGN) Enters $2.32B Collaboration With Parabilis to Target ‘Undruggable’ Proteins
  Mon, May 25, 2026 7:54 PM

Financial data not available